Back |
home / stock / rtrx / rtrx message board
Subject | By | Source | When |
---|---|---|---|
Anybody alive out there on the News. Anything | dennisb | investorshub | 07/14/2014 4:11:21 PM |
That is what makes a market. | zipjet | investorshub | 06/30/2014 10:04:42 PM |
I covered awhile ago. Got bored having | kittzelle | investorshub | 06/30/2014 12:25:19 AM |
Are you buying puts? | zipjet | investorshub | 06/29/2014 7:54:56 PM |
Why is this not at $9 yet? | kittzelle | investorshub | 06/16/2014 7:05:47 PM |
Come on already, just dump. | kittzelle | investorshub | 06/11/2014 6:06:18 PM |
I picked up some puts other day. | kittzelle | investorshub | 06/06/2014 6:27:28 PM |
Good news today: | dennisb | investorshub | 05/30/2014 2:38:13 PM |
What's going on here we keep falling: it | dennisb | investorshub | 05/08/2014 8:29:42 PM |
$RTRX is discussed from time to time on | DewDiligence | investorshub | 05/02/2014 10:10:23 PM |
Anybody alive out their:any News!!!! | dennisb | investorshub | 04/29/2014 10:31:39 PM |
Anybody has any news out there: | dennisb | investorshub | 04/17/2014 12:06:28 AM |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced completion of patient enrollment in the Phase 3 DUPLEX Study. The pivotal DUPLEX Study is evaluating the safety and efficacy of sparsentan for the treatment of focal segmental glomerulosclerosis...
New name reflects dedication to patient- inspired mission of identifying, developing and delivering life-changing rare disease therapies Company’s s hares to t rade u nder n ew t icker s ymbol TVTX on Novem...
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58...